These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26120944)

  • 1. Drug-Induced Systemic Hypersensitivity Reaction Associated With Ziprasidone: An Atypical Occurrence.
    Lister JF; Voinov B; Thimothy L; Bean JR
    J Clin Psychopharmacol; 2015 Aug; 35(4):478-80. PubMed ID: 26120944
    [No Abstract]   [Full Text] [Related]  

  • 2. Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
    Kim MS; Kim SW; Han TY; Son SJ; Lee JH; Kim EJ
    Int J Dermatol; 2014 Apr; 53(4):e267-8. PubMed ID: 24117439
    [No Abstract]   [Full Text] [Related]  

  • 3. US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone.
    Chan VC; La Grenade L; Diak IL; Levin RL
    J Clin Psychiatry; 2015 Sep; 76(9):e1138-9. PubMed ID: 26455682
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
    Tsai CF; Tsai SJ; Hwang JP
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):797-9. PubMed ID: 16035110
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.
    Eker SS; Sarandol A; Akkaya C; Sivrioglu EY; Kirli S
    J Psychopharmacol; 2009 Nov; 23(8):993-6. PubMed ID: 18635710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin syndrome caused by ziprasidone alone.
    Lin PY; Hong CJ; Tsai SJ
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):338-9. PubMed ID: 20602736
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia and ziprasidone.
    Rosenquist KJ; Walker SS; Ghaemi SN
    Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846
    [No Abstract]   [Full Text] [Related]  

  • 8. Tardive dystonia associated with ziprasidone.
    Papapetropoulos S; Wheeler S; Singer C
    Am J Psychiatry; 2005 Nov; 162(11):2191. PubMed ID: 16263868
    [No Abstract]   [Full Text] [Related]  

  • 9. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden akathisia after a ziprasidone dose reduction.
    Oral ET; Altinbas K; Demirkiran S
    Am J Psychiatry; 2006 Mar; 163(3):546. PubMed ID: 16513883
    [No Abstract]   [Full Text] [Related]  

  • 11. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kounis syndrome and ziprasidone.
    Hamera L; Khishfe BF
    Am J Emerg Med; 2017 Mar; 35(3):493-494. PubMed ID: 27919473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone induced tardive cervical dystonia.
    Kutlu A; Dündar S; Altun NS; Budak F
    Psychopharmacol Bull; 2009; 42(4):64-8. PubMed ID: 20581794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 17. Ziprasidone-induced tardive dyskinesia in a patient without known risk factors.
    Sinha P; Rao R; Sharan P
    Natl Med J India; 2007; 20(5):271-2. PubMed ID: 18254531
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.
    Duggal HS
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):108-9. PubMed ID: 18305296
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
    Mellacheruvu S; Norton JW; Schweinfurth J
    J Clin Psychopharmacol; 2007 Apr; 27(2):206-7. PubMed ID: 17414248
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone-induced acute laryngeal dystonia.
    Duggal HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):970; author reply 971. PubMed ID: 17343967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.